The popularity of antibiotics in the outpatient prescription market continues. The prescription market for cephalosporin-class antibiotics has nearly doubled in the past 3 years. This ‘heyday’ in the cephalosporin prescription market is continuing, fueled by the steady increase in flu and cold cases since the end of the pandemic.

According to the market research institution UBIST, the outpatient prescription market for cephalosporin antibiotics was KRW 80.4 billion in Q1 last year, up 11.3% year-on-year. Compared to the KRW 64.1 billion it posted in Q1 2022, the market has expanded 24.4% in 2 years.

Cephalosporin antibiotics, which are also called ‘Cepha antibiotics,’ are anti